Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) and PROCEPT BioRobotics (NASDAQ:PRCT – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, institutional ownership, valuation, earnings and analyst recommendations.
Analyst Recommendations
This is a breakdown of recent ratings and price targets for Kewaunee Scientific and PROCEPT BioRobotics, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Kewaunee Scientific | 0 | 1 | 0 | 0 | 2.00 |
| PROCEPT BioRobotics | 2 | 9 | 2 | 3 | 2.38 |
PROCEPT BioRobotics has a consensus target price of $25.50, indicating a potential upside of 25.62%. Given PROCEPT BioRobotics’ stronger consensus rating and higher possible upside, analysts clearly believe PROCEPT BioRobotics is more favorable than Kewaunee Scientific.
Valuation and Earnings
This table compares Kewaunee Scientific and PROCEPT BioRobotics”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Kewaunee Scientific | $282.00 million | 0.34 | $9.62 million | $2.76 | 12.14 |
| PROCEPT BioRobotics | $308.05 million | 3.77 | -$95.57 million | ($1.94) | -10.46 |
Kewaunee Scientific has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Kewaunee Scientific, indicating that it is currently the more affordable of the two stocks.
Insider & Institutional Ownership
32.7% of Kewaunee Scientific shares are held by institutional investors. Comparatively, 89.5% of PROCEPT BioRobotics shares are held by institutional investors. 14.1% of Kewaunee Scientific shares are held by company insiders. Comparatively, 4.0% of PROCEPT BioRobotics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Profitability
This table compares Kewaunee Scientific and PROCEPT BioRobotics’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Kewaunee Scientific | 2.97% | 11.61% | 4.82% |
| PROCEPT BioRobotics | -32.53% | -30.62% | -22.10% |
Volatility and Risk
Kewaunee Scientific has a beta of 0.76, indicating that its stock price is 24% less volatile than the S&P 500. Comparatively, PROCEPT BioRobotics has a beta of 0.92, indicating that its stock price is 8% less volatile than the S&P 500.
Summary
PROCEPT BioRobotics beats Kewaunee Scientific on 8 of the 14 factors compared between the two stocks.
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks. The company's laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; and technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture. It sells its products primarily through dealers, its subidiaries, and a national distributor. The company was founded in 1906 and is headquartered in Statesville, North Carolina.
About PROCEPT BioRobotics
PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). It also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
